Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

SYBT vs BMA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

SYBT Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 7–3 Matrix Metrics)

SYBT Overall Winner 6-Pillar Tally: SYBT 3 – 2 BMA (1 Tie) Matrix Metrics: SYBT 7 – 3 BMA

As of Nov 16, 2026, Stock Yards Bancorp, Inc. (SYBT) is the stronger overall head-to-head candidate over Banco Macro S.A. (BMA) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). SYBT carries a Unified Composite Score of 40.7/100 (SELL) at $77.96 (13.6x Forward P/E, 48.5% operating margin), whereas BMA carries 39.3/100 (SELL) at $54.28 (3.1x Forward P/E, 18.0% operating margin).

  • Defensive Composite Rating Caution: Although SYBT compares more favorably head-to-head, both SYBT (40.7/100 SELL) and BMA (39.3/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: SYBT is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 47.1); meanwhile BMA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About SYBT vs BMA
SYBT NASDAQ Head-to-Head Winner
Stock Yards Bancorp, Inc.
State Commercial Banks
$77.96
-1.49% 1D
Market Cap $2.5B
TTM Revenue $438M
Forward P/E 13.6x
Beta / 30D Vol 0.33β · 26% Vol
Unified Composite Score
40.7 / 100 SELL
Tech 43.0 Fund 42.0 Flow 50.0 Mom 31.1
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -1.3%) with fading momentum, RSI 47
RSI-14: 47.1 · SMA20: $79.07 · SMA50: $78.26
BMA NYSE
Banco Macro S.A.
Commercial Banks, Nec
$54.28
-4.54% 1D
Market Cap $3.6B
TTM Revenue $3.48B
Forward P/E 3.1x
Beta / 30D Vol 1.41β · 41% Vol
Unified Composite Score
39.3 / 100 SELL
Tech 29.0 Fund 45.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.8%), weak momentum, RSI 31
RSI-14: 30.7 · SMA20: $59.84 · SMA50: $66.06

6-Pillar Scorecard Institutional Category Breakdown (SYBT 3 – 2 BMA)

Columns: Metric · SYBT · BMA
1. Valuation Multiples BMA
Forward P/E 13.6x 3.1x
Trailing P/E 15.3x 11.4x
PEG Ratio 1.33x 0.47x
EV / Revenue 5.6x 1.0x
2. Growth & Scale SYBT
Revenue Growth (YoY) +19.8% +1.2%
Earnings Growth (YoY) +13.8% +3.5%
TTM Revenue (USD) $438M $3.48B
Market Cap $2.5B $3.6B
3. Profitability & Quality SYBT
Gross Margin 100.0% 98.7%
Operating Margin 48.5% 18.0%
Net Profit Margin 35.8% 9.0%
Return on Equity (ROE) 13.6% 7.1%
4. Balance Sheet & Cash Flow SYBT
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $40.79 Book/Sh · 13.6% ROE $64.45 Book/Sh · 7.1% ROE
Dividend Yield 1.62% None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 34.2% (4th %ile) 77.3% (51st %ile)
Put/Call OI Skew N/A Thin ADR Chain
OBV Trend / Tech Phase NEUTRAL · Distribution NEUTRAL · Markdown
6. R&D & Supply-Chain Moat BMA
OpEx & R&D Intensity 51.5% of Rev ($226M) 80.7% of Rev ($2.81B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Scale & Operating Efficiency Moat
Supply-Chain Role Banks - Regional Operator Banks - Regional Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: SYBT (7) vs BMA (3)
Institutional Metric SYBT BMA Criterion Row Edge
Market Capitalization
Scale
$2.5B $3.6B Larger Scale BMA
Trailing P/E Ratio
Valuation
15.3x 11.4x Lower Multiple BMA
Forward P/E Ratio
Valuation
13.6x 3.1x Lower Multiple BMA
Revenue Growth (YoY)
Growth
+19.8% +1.2% Higher Growth SYBT
Operating Margin (TTM)
Profitability
48.5% 18.0% Higher Margin SYBT
Net Profit Margin
Profitability
35.8% 9.0% Higher Margin SYBT
Return on Equity (ROE)
Capital Efficiency
13.6% 7.1% Higher ROE SYBT
52-Week Range Position
Momentum
59% ($62–$89) 0% ($54–$106) Stronger Trend SYBT
Beta / 30D Volatility
Risk Regime
0.33β · 26% Vol 1.41β · 41% Vol Lower Realized Risk SYBT
Unified Institutional Score
Composite Signal
40.7 / 100 (SELL) 39.3 / 100 (SELL) Higher Composite SYBT
Trailing 12M Revenue (USD)
Operating Scale
$438M $3.48B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
100.0% 98.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.33x PEG · 5.6x EV/Rev 0.47x PEG · 1.0x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($40.79 Book/Sh · 13.6% ROE) N/A ($64.45 Book/Sh · 7.1% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SYBT +16.9 pp
SYBT: +1.66% · BMA: -15.24%
3M Horizon SYBT +21.79 pp
SYBT: -6.86% · BMA: -28.65%
6M Horizon SYBT +35.63 pp
SYBT: +10.42% · BMA: -25.21%
1Y Horizon SYBT +51.1 pp
SYBT: +16.38% · BMA: -34.72%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SYBT vs BMA. Trailing 12-month operating profitability (SYBT 48.5% vs BMA 18.0%) and valuation multiples (SYBT 13.6x vs BMA 3.1x Forward P/E) are benchmarked directly in Pillar 4 below.

SYBT ADR TTM Benchmark FX-Normalized USD
TTM Revenue$438M
Gross Margin100.0%
Op. Margin48.5%
ROE / Fwd P/E13.6% · 13.6x
BMA ADR TTM Benchmark FX-Normalized USD
TTM Revenue$3.48B
Gross Margin98.7%
Op. Margin18.0%
ROE / Fwd P/E7.1% · 3.1x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
SYBT UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 34.2%
IV Percentile 4th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SYBT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
BMA UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 77.3%
IV Percentile 51st %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BMA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
SYBT Moat Profile High-Margin Pricing Power Moat
Banks - Regional Operator
Competes within the Banks - Regional value chain with $2.5B market capitalization and 48.5% operating margin.
OpEx & R&D Reinvestment 51.5% of Rev ($226M)
90D Engineering Disclosures 0 Published
BMA Moat Profile Scale & Operating Efficiency Moat
Banks - Regional Operator
Competes within the Banks - Regional value chain with $3.6B market capitalization and 18.0% operating margin.
OpEx & R&D Reinvestment 80.7% of Rev ($2.81B)
90D Engineering Disclosures 0 Published

Investor FAQ SYBT vs BMA Key Questions & Quantitative Answers

As of Nov 16, 2026, Stock Yards Bancorp, Inc. (SYBT) is the stronger overall head-to-head candidate over Banco Macro S.A. (BMA) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). SYBT carries a Unified Composite Score of 40.7/100 (SELL) at $77.96 (13.6x Forward P/E, 48.5% operating margin), whereas BMA carries 39.3/100 (SELL) at $54.28 (3.1x Forward P/E, 18.0% operating margin). Defensive Composite Rating Caution: Although SYBT compares more favorably head-to-head, both SYBT (40.7/100 SELL) and BMA (39.3/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: SYBT is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 47.1); meanwhile BMA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

SYBT leads the Growth & Scale pillar: SYBT posts +19.8% YoY revenue growth and +13.8% YoY earnings growth on $438M TTM revenue (100.0% gross margin, 48.5% operating margin), compared with BMA at +1.2% YoY revenue growth and +3.5% YoY earnings growth on $3.48B TTM revenue (98.7% gross margin, 18.0% operating margin). On trailing 12-month operating scale, SYBT generates $438M in USD-normalized revenue versus $3.48B for BMA. In operating R&D and SG&A reinvestment, SYBT deploys 51.5% of Rev ($226M) (0 90-day corporate R&D disclosures) versus 80.7% of Rev ($2.81B) (0 disclosures) for BMA.

BMA screens cheaper on headline valuation multiples. SYBT trades at 13.6x Forward P/E, 15.3x Trailing P/E, 1.33x PEG, and 5.6x EV/Revenue (unreported cash flow margin), whereas BMA trades at 3.1x Forward P/E, 11.4x Trailing P/E, 0.47x PEG, and 1.0x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SYBT (13.6% ROE) versus BMA (7.1% ROE) capital efficiency.

In options market volatility and institutional positioning, SYBT carries 34.2% implied volatility (4th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.33β · 26% Vol realized risk). By comparison, BMA carries 77.3% implied volatility (51st %ile, Balanced (25th–60th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.41β · 41% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.